NMVLX | VMVAX | NMVLX / VMVAX | |
Total Expense Ratio | 0.94 | 0.07 | 1,343% |
Annual Report Gross Expense Ratio | 0.99 | 0.07 | 1,414% |
Fund Existence | 11 years | 14 years | - |
Gain YTD | -2.412 | -0.023 | 10,644% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 3000 | 333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 514M | 29.9B | 2% |
Annual Yield % from dividends | 3.68 | 2.31 | 159% |
Returns for 1 year | -1.20 | 7.23 | -17% |
Returns for 3 years | -0.63 | 24.99 | -3% |
Returns for 5 years | 3.81 | 69.23 | 6% |
Returns for 10 years | 25.07 | 78.81 | 32% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IRPSX | 11.12 | -0.12 | -1.07% |
VY® T. Rowe Price Equity Income S | |||
CGVHX | 25.60 | -0.33 | -1.27% |
American Funds Global Insight 529-F-3 | |||
MIELX | 8.95 | -0.12 | -1.32% |
MassMutual International Eq Adm | |||
NGUAX | 29.86 | -0.45 | -1.48% |
Neuberger Berman Large Cap Growth Inv | |||
FCIWX | 17.51 | -0.34 | -1.90% |
NYLI PineStone International Eq Cl R6 |